QP
TEVA icon

Quilter Plc’s Teva Pharmaceuticals TEVA Stock Holding History

Quilter Plc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,125
Closed -$3.12M – 223
2023
Q3 		$3.12M Hold
3,125
– – 0.01% 117
2023
Q2 		$3.1M Hold
3,125
– – 0.01% 122
2023
Q1 		$3.1M Buy
+3,125
New +$30.9K 0.01% 115
2021
Q4 		– Sell
-15,844
Closed -$154K – 296
2021
Q3 		$154K Buy
15,844
+166
+1% +$1.55K ﹤0.01% 292
2021
Q2 		$155K Buy
+15,678
New +$166K ﹤0.01% 313
2021
Q1 		– Sell
-10,180
Closed -$98K – 376
2020
Q4 		$98K Sell
10,180
-703
-6% -$6.74K ﹤0.01% 277
2020
Q3 		$98K Sell
10,883
-9,154
-46% -$96.8K ﹤0.01% 260
2020
Q2 		$246K Sell
20,037
-10,679
-35% -$121K 0.01% 205
2020
Q1 		$275K Buy
30,716
+3,712
+14% +$38K 0.02% 175
2019
Q4 		$265K Buy
+27,004
New +$241K 0.02% 172

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Quilter Plc's TEVA Position: Q4 2023 in Review

Quilter Plc sold out of Teva Pharmaceuticals (TEVA) in Q4 2023, closing a stake of 3,125 shares — an estimated $3.12M sold.

Quilter Plc first reported a position in TEVA in Q4 2019 and held it in 10 quarters. The position peaked at $3.12M in Q3 2023. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • Quilter Plc reported no remaining Teva Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Quilter Plc sold 3,125 Teva Pharmaceuticals shares in Q4 2023, an estimated $3.12M.
  • Quilter Plc first reported a position in Teva Pharmaceuticals in Q4 2019 and held it in 10 quarters.
  • Quilter Plc's Teva Pharmaceuticals position peaked at $3.12M in Q3 2023.
  • 447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on Quilter Plc's 13F filing for Q4 2023, filed 24 Jan 2024.